Purdue Pharma’s reckoning over the company’s promotion of OxyContin contributing to an opioid epidemic has spread to the company’s marketing partners.

WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in